KineMed Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:KineMed Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0133
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
KineMed Inc (KineMed) is a biotechnology company that develops and commercializes proprietary biomarker platform technology. The company applies its proprietary biomarker platform technology to drug development, prescription, and non-prescription medical diagnostics and the pairing of drugs with diagnostic biomarker tests. It utilizes isotope labeling, mass spectrometry, and other techniques to observe the activity of biochemical pathways, measure molecular fluxes within the pathways, and to monitor the appearance and disappearance of individual proteins and biological biomarkers. Kinmed develops drugs in the therapeutic areas of muscle metabolism, fibrosis, immunity, neurobiology, diabetes, cancer, and others. The company also conducts pharmaceutical research on molecular targets and deconstructed systems. KineMed is headquartered in Emeryville, California, the US.

KineMed Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
KineMed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
KineMed Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
KineMed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
KineMed Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
KineMed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
KineMed Inc, Medical Equipment, Deal Details 10
Partnerships 10
KineMed Extends Co-Development Agreement with CHDI Foundation 10
KineMed Enters Into Co-Development Agreement With Amgen For Kinetic Biomarkers Of Brain Proteinopathies 11
KineMed, Isis Pharma And CHDI Foundation Enter Into Co-Development Agreement For Companion Biomarker 12
KineMed Enters Into Co-Development Agreement With GlaxoSmithKline 13
KineMed Enters Into Co-Development Agreement With CHDI Foundation 14
KineMed Inc – Key Competitors 15
KineMed Inc – Key Employees 16
KineMed Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
KineMed Inc, Medical Equipment, Key Facts 2
KineMed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
KineMed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
KineMed Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
KineMed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
KineMed Inc, Deals By Market, 2012 to YTD 2018 8
KineMed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
KineMed Extends Co-Development Agreement with CHDI Foundation 10
KineMed Enters Into Co-Development Agreement With Amgen For Kinetic Biomarkers Of Brain Proteinopathies 11
KineMed, Isis Pharma And CHDI Foundation Enter Into Co-Development Agreement For Companion Biomarker 12
KineMed Enters Into Co-Development Agreement With GlaxoSmithKline 13
KineMed Enters Into Co-Development Agreement With CHDI Foundation 14
KineMed Inc, Key Competitors 15
KineMed Inc, Key Employees 16

List of Figures
KineMed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
KineMed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
KineMed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
KineMed Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
KineMed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
KineMed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
KineMed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
KineMed Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[KineMed Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Brookfield Asset Management Inc.:戦略・SWOT・企業財務分析
    Brookfield Asset Management Inc. - Strategy, SWOT and Corporate Finance Report Summary Brookfield Asset Management Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Ameresco Inc (AMRC):電力:M&Aディール及び事業提携情報
    Summary Ameresco, Inc. (Ameresco) provides comprehensive energy services, including energy efficiency, infrastructure upgrades, asset sustainability and renewable energy solutions. It also offers energy infrastructure facility upgrade; and development, construction and operation of renewable energy …
  • Beacon Roofing Supply Inc:企業の戦略・SWOT・財務分析
    Beacon Roofing Supply Inc - Strategy, SWOT and Corporate Finance Report Summary Beacon Roofing Supply Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • General Cable Corp:電力:M&Aディール及び事業提携情報
    Summary General Cable Corp (General Cable), a subsidiary of Prysmian Group, produces and sells wires and cables. It develops, designs, manufactures, markets and distributes copper, aluminum and fiber optic wire and cable products for the energy, industrial, specialty, construction and communications …
  • eircom Limited (eir):戦略・SWOT・企業財務分析
    eircom Limited (eir) - Strategy, SWOT and Corporate Finance Report Summary eircom Limited (eir) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • GeNeuro SA (GNRO):製薬・医療:M&Aディール及び事業提携情報
    Summary GeNeuro SA (GeNeuro) is a clinical stage pharmaceutical company that manufactures therapeutic product pipeline for disorders of the nervous system. The company provides treatments against inflammatory and degenerative disorders associated with endogenous retroviruses. GeNeuro develops therap …
  • Equinor ASA (EQNR):企業の財務・戦略的SWOT分析
    Equinor ASA (EQNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Lake Shore Gold Corp.:企業のM&A・事業提携・投資動向
    Lake Shore Gold Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lake Shore Gold Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • PG&E Corp (PCG):企業の財務・戦略的SWOT分析
    PG&E Corp (PCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Change Healthcare, LLC:企業の戦略的SWOT分析
    Change Healthcare, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • H&E Equipment Services Inc (HEES):企業の財務・戦略的SWOT分析
    Summary H&E Equipment Services Inc (H&E Equipment) is an integrated equipment company that provides rentals and sales services. The company rents, sells and provides parts and service support for new and used earthmoving equipments, material handling, forestry, concrete, industrial and heavy equipme …
  • Cedars-Sinai Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary Cedars-Sinai Medical Center (Cedars-Sinai), formerly Kaspare Cohn Hospital is an academic and medical center that provides healthcare services for patients and medical professionals, and research and education services. The center offers treatments for various conditions such as abdominal pa …
  • MAN Diesel & Turbo SE-エネルギー分野:企業M&A・提携分析
    Summary MAN Diesel & Turbo SE (MAN Diesel), a subsidiary of MAN SE, is a large-bore diesel engines and turbomachinery provider. Its product portfolio includes turbochargers, propellers, gas engines and chemical reactors; and goods include marine propulsion systems, turbomachinery units for oil and g …
  • Admedes GmbH:企業の戦略的SWOT分析
    Admedes GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Olin Corporation
    Olin Corporation - Strategy, SWOT and Corporate Finance Report Summary Olin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ausgrid-エネルギー分野:企業M&A・提携分析
    Summary Ausgrid is a state-owned electric corporation. It transmits, distributes, and retails electricity through transmission and distribution networks. The company also offers street lighting, tree trimming, combating graffiti, energy efficiency, installation and connection of small scale embedded …
  • Emisphere Technologies Inc (EMIS):企業の戦略的SWOT分析
    Emisphere Technologies Inc (EMIS) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Xintela AB (XINT):企業の財務・戦略的SWOT分析
    Summary Xintela AB (Xintela) is a biomedical company that develops treatment for cartilage damage and brain tumors. The company’s technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also o …
  • Texas Health Resources:企業の戦略的SWOT分析
    Texas Health Resources - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Brunei LNG Sdn Bhd:企業の戦略的SWOT分析
    Brunei LNG Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆